Table 1

Main clinical characteristics of the 24 patients included in the study

Patient numberGenderAge at treatment (years)Psychiatric comorbiditiesMovement disorderBody regionOnsetDuration before repeated TMS treatment (years)Efficiency on total score (%)Duration of follow-up (months)/CGI score*Number of relapses (efficiency of following repeated TMS)
1F60.0BipolarJerky dystoniaULSudden0.572.210.1/03 (+)
2F30.6DepressionDystoniaLeft sideSudden9.996.321.7/10
3M49.8NoMyoclonusNeck+ULProgressive4100.022/52 (+)
4F60.6NoDystoniaRight sideSudden0.789.321.3/12 (+)
5M38.9NoParkinsonismWhole bodySubacute25.257.619.9/20
6M43.9NoDystoniaLeft sideSubacute3.537.718.3/40
7M38.2Drug abuseJerky dystoniaWhole bodySubacute1.753.323.1/21 (+)
8F32.9NoDystoniaUL+LLProgressive2236.434.6/24 (+)
9F57.3DepressionJerky dystoniaHandsProgressive30.250.019.2/31 (+)
10M54.2NoDystoniaLeft ULSudden3.2100.019.4/10
11F24.2NoDystoniaRight handSudden2.4100.019.7/11 (+)
12F53.0NoDystoniaRight LLSubacute1.137.519.4/10
13F21.9NoDystoniaRight ULProgressive3100.022/20
14F34.7NoDystoniaTrunk and LLSudden2.5100.019.7/32 (+)
15F75.9DepressionMyoclonusLLSubacute1.362.517.6/60
16F43.6BipolarDystoniaLLProgressive1.910.523.1/40
17F47.4DepressionTremorRight ULSubacute2100.021.7/20
18F35.8NoTremorULProgressive23.373.318.5/22 (+)
19F25.0NoDystoniaRight ULSudden11.875.023.1/33 (+)
20M55.6NoMyoclonusTrunk+LLProgressive0.726.927.3/41 (+)
21F51.3NoStereotypiesUL+LLProgressive3.717.925.4/30
22M56.7NoMyoclonusTrunk+LLSudden1.488.214.6/20
23F40.2NoMyoclonusUL+LLSudden0.759.31.9/00
24M35.5NoTremorWhole bodySubacute6.851.912.8/34 (+)
Median43.72.867.419.8/2
Mean44.56.866.519.9/2.6
  • Sudden, in <24 h; subacute, 24 h–1 month; progressive, >1 month.

  • +, positive effect of the low-frequency repeated TMS.

  • *CGI score performed at the end of follow-up. CGI-I=1, very much improved; CGI-I=2, much improved; CGI-I=3, minimally improved; CGI-I=4, no change; CGI-I=5, minimally worse; CGI-I=6, much worse; CGI-I=7, very much worse.

  • CGI, Clinical Global Impression; LL, lower limbs; TMS, transcranial magnetic stimulation; UL, upper limbs.